Evidence derived from cell marking and lineage tracing in mouse and chicken embryos indicates that the CLE, the region of epiblast flanking the rostral primitive streak, serves as the common precursor pool for the paraxial mesoderm and caudal neural plate which later contributes to the caudal hindbrain and spinal cord[@R1],[@R2],[@R7]. The bipotential precursors serve as the pool of "axial stem cells" that contributes to the coordinated elongation of the neural tube, which develops from the cell population remaining in the superficial layer, and paraxial mesoderm, derived from cells that ingress through the primitive streak[@R8]-[@R10]. The most compelling evidence for this was provided by the single cell lineage analysis reported by Tzouanacou et al.[@R8], who utilized intragenic recombination in a transgene to mark a clone, and demonstrated that a substantial fraction of individual axial stem cells do produce progenies of both cell fates. However, the regulatory mechanism underlying this neural versus mesodermal fate choice remained to be elucidated.

Expression of the transcription factor gene *Sox2* is regarded as the hallmark of the neural primordial cell state, and its activation is strongly correlated with the establishment of the embryonic neural plate ([Fig.1b](#F1){ref-type="fig"}; [Supplementary Fig.1](#SD3){ref-type="supplementary-material"}). Our earlier studies have indicated that among a number of enhancers regulating *Sox2*, enhancer N1 is responsible for *Sox2* activation in the caudally extending neural plate[@R5],[@R6] ([Fig.1a-c](#F1){ref-type="fig"}; [Supplementary Fig.1](#SD3){ref-type="supplementary-material"}). Followong features of enhancer N1 indicate its involvement in the regulation of CLE-derived cells[@R4]: (1) Enhancer N1 is activated precisely in the region of the CLE, and sustained in the [z]{.ul}one at the [c]{.ul}audal end of [n]{.ul}eural [p]{.ul}late (ZCNP) ([Fig.1b,c](#F1){ref-type="fig"}). Its activation, however, does not immediately lead to *Sox2* expression in the CLE, owing to BMP signal-dependent repression of *Sox2* in the CLE. Only when the CLE cells become a part of ZCNP located immediately rostral, the cells are relieved from the BMP signal and initiate *Sox2* expression. In fact, the inhibition of BMP signals results in precocious *Sox2* activation in the entire CLE[@R4]([Supplementary Fig.2](#SD3){ref-type="supplementary-material"}). (2) Enhancer N1 activity is normally shut off in the mesodermal precursors that have ingressed through the primitive streak, suggestive of the release of this cell population from a neural fate[@R4]. (3) Enhancer N1 is activated by the synergistic action of Wnt and Fgf signals[@R4]([Fig.1d,e](#F1){ref-type="fig"}), while the Fgf signal is required for the maintenance of the axial stem cells in the CLE[@R1],[@R11],[@R12]. Based on these observations, we hypothesized that regulation of *Sox2* through enhancer N1 is an important mechanism to regulate cell fate in the CLE.

Given the CLE origin of paraxial mesoderm, the phenotype of *Tbx6* null mutant embryos is remarkable, where bilateral ectopic neural tubes develop at the expense of the paraxial mesoderm caudal to somite 6 level[@R3]. *Tbx6*, encoding a T-box transcription factor, is expressed in the primitive streak and presomitic paraxial mesoderm during gastrulation[@R13]([Fig.1f](#F1){ref-type="fig"}), and is presumed to have two major regulatory functions: (1) anti-neural fate regulation in the presomitic mesoderm, as indicated by the mutant phenotype, and (2) regulation of later somite segmentation involving *Mesp2* and *Dll-1* genes[@R14]-[@R17].

We investigated the process of ectopic neural tube development from the presumptive paraxial mesoderm in homozygous *Tbx6* mutant embryos. In *Tbx6* mutant embryos at E8.5, mesoderm development is already defective, as indicated by the absence of the normal pattern of *Uncx4.1* expression in the caudal part of segmented somites ([Supplementary Fig.3a](#SD3){ref-type="supplementary-material"}). The expression of *Sox2* in normal embryos at E8.5 (5\~6 somites) was confined to the neural plate and neural tube ([Fig.2a](#F2){ref-type="fig"}), whereas in *Tbx6* mutant embryos, the cells in the paraxial mesodermal compartment underlying the neural plate fully expressed *Sox2*, at levels comparable to those in the neural plate ([Fig.2b](#F2){ref-type="fig"}). The ectopic *Sox2* expression was followed by the ectopic development of neural tubes in the same compartment at E9.5 ([Fig.2c,d](#F2){ref-type="fig"}), where genes such as *Pax6* and *Pax3* were expressed, indicating the development of the dorso-ventral patterning of the ectopic neural tubes[@R3] (see also [Fig.3](#F3){ref-type="fig"}).

In contrast to *Sox2,* other group B1 *Sox* genes, *Sox1* and *Sox3* that are normally expressed in the neural tube, were not activated in the paraxial mesodermal compartment ([Fig.2e-h](#F2){ref-type="fig"}). This observation strongly suggests that the activation of *Sox2* in the paraxial mesodermal compartment is causative of ectopic neural tube development in *Tbx6* mutant embryos.

By analogy to the process of caudal neural plate development, we speculated involvement of enhancer N1 activation, leading to *Sox2* expression, in ectopic neural tube development in *Tbx6* mutant embryos. To test this model, we compared enhancer N1 activity in *Tbx6* mutant and wild type embryos ([Fig.2i,j](#F2){ref-type="fig"}; [Supplementary Fig.3b](#SD3){ref-type="supplementary-material"}) using enhancer N1-driven transgenes for *Egfp* (for in situ hybridization detection of transcripts) or *LacZ* (for histochemical enzyme staining). In wild-type embryos, enhancer N1-dependent *Egfp* expression was clearly detected in the CLE and primitive streak, but not in the paraxial mesodermal compartment ([Fig.2i](#F2){ref-type="fig"}). Analysis of serial sections suggested that enhancer N1 loses its activity after the cells ingress through the primitive streak and when the cells migrate laterally into the mesodermal compartment ([Fig.2i',i"](#F2){ref-type="fig"}). In contrast to the primitive streak-restricted *Egfp* transcript in the mesodermal layer, more stable LacZ enzyme activity was detected in more laterally positioned cells. This observation is consistent with the model that the cells turn off enhancer N1 before migrating laterally ([Supplementary Fig.3b](#SD3){ref-type="supplementary-material"}). An analogous sequence of events occurs in chicken embryos[@R4].

Remarkably, in the *Tbx6* mutant embryos, enhancer N1 activation persisted in the paraxial mesodermal compartment, as indicated by strong *Egfp* and LacZ expression ([Fig.2j](#F2){ref-type="fig"}, [Supplementary Fig.3b](#SD3){ref-type="supplementary-material"}). Even in *Tbx6* mutants, the trans-layer cell ingression pathway appears to be confined to the primitive streak, as the laminin-positive basal lamina separating the epiblastic and mesodermal cells was interrupted only in the primitive streak region ([Supplementary Fig.3c](#SD3){ref-type="supplementary-material"}). These observations indicate that the persistent activity of enhancer N1 in the paraxial mesodermal compartment caused ectopic *Sox2* expression, which in turn leads to the development of ectopic neural tubes. Conversely, this suggests that in normal embryos the activity of Tbx6 expressed in the paraxial mesoderm suppresses enhancer N1 activation, thereby preventing the development of neural tubes from the mesodermal precursors.

To confirm that the *Sox2* misexpression in the paraxial mesoderm compartment in *Tbx6* mutant embryos, leading to supernumerary neural tube development, is due to the ectopic activation of enhancer N1, we produced an enhancer N1 mutant allele in the mouse, in which only the enhancer N1 sequence was deleted from the *Sox2* locus ([Supplementary Fig.4](#SD3){ref-type="supplementary-material"}). Homozygosity for the enhancer N1 mutation (ΔN1/ΔN1) caused the loss of *Sox2* expression in the ZCNP, which is the nascent neural plate positioned immediately rostral to the CLE[@R1],[@R2],[@R12]. This loss of *Sox2* expression in the ZCNP in the ΔN1/ΔN1 embryos was noticeable after the 5-somite stages (E8.5)([Fig.3b](#F3){ref-type="fig"}), consistent with the timing of enhancer N1 activation ([Fig.1c](#F1){ref-type="fig"}), and continued to E9.5. Despite this, *Sox2* was activated in the closing neural tube, and the development of the spinal cord proceeded without significant morphological defects ([Fig.3b](#F3){ref-type="fig"}). We presume this to be ascribable to the presence of another enhancer to back up *Sox2* expression in the neural tube, and/or other group B1 *Sox* genes expressed in the neural plate to compensate for the role of *Sox2*.

By crossing *Tbx6*+/−;+/ΔN1 double heterozygotes, *Tbx6*−/−;ΔN1/ΔN1 double homozygous mutant embryos were successfully obtained. In *Tbx6*−/−;ΔN1/ΔN1 embryos at E8.5, the ectopic *Sox2* expression in the paraxial mesodermal compartment was totally absent ([Fig.3d,d'](#F3){ref-type="fig"}), in contrast to the case of *Tbx6*−/− embryos ([Fig.3c,c'](#F3){ref-type="fig"}), providing strong evidence that enhancer N1 determines the ectopic expression of *Sox2* in *Tbx6* mutants.

In the ectopic neural tubes that develop in *Tbx6*−/− embryos at E9.5, *Sox2* expression continues, while expression of other genes that are associated with neural tube development also initiates, namely *Sox1, Pax6*, and *Pax3*, the latter two reflecting the dorso-ventral identity of the neural tube[@R3] ([Fig.3](#F3){ref-type="fig"}, [Supplementary Fig.5](#SD3){ref-type="supplementary-material"}). In the *Tbx6*−/−;ΔN1/ΔN1 embryos at E9.5, however, the expression of all these neural genes in the paraxial compartment was extinct, concomitant with the absence of the tubular structure ([Fig.3](#F3){ref-type="fig"}). The paraxial tissue in the *Tbx6*−/−;ΔN1/ΔN1 embryos failed to express any of the mesoderm or endoderm marker genes examined, namely *Pax3* ([Fig.3g](#F3){ref-type="fig"}) and *Mox1* for paraxial mesoderm, *Pax2* for intermediate mesoderm, *Foxf1* for visceral lateral plate mesoderm, and *Foxa1* for endoderm ([Supplementary Fig.5](#SD3){ref-type="supplementary-material"}). These observations indicate that Tbx6 has two distinct functions in the mesodermal precursors: the inhibition of neural development by preventing enhancer N1 activation, and the promotion of mesodermal development.

To confirm that the *Sox2* misexpression in the paraxial mesoderm is causative of the ectopic neural tube development, HA-tagged *Sox2* was ectopically expressed in the primitive paraxial mesoderm of wild type embryos using the msd enhancer of the *Dll1* gene[@R18]([Fig.4a](#F4){ref-type="fig"}). Exogenous Sox2-HA was successfully expressed in the caudal-most mesodermal compartment ([Fig.4b](#F4){ref-type="fig"}), as indicated by HA-tag immunostaining and the mesodermal Sox2 immunostaining ([Fig.4c-e](#F4){ref-type="fig"}). At a more rostral level of the paraxial mesoderm, where the msd enhancer activity was lost and exogenous Sox2-HA expression had ceased, endogenous Sox2 expression persisted, indicating a positive feedback loop, where the former activated the latter. Notably, the clusters of cells with relatively high Sox2 also expressed Pax6 ([Fig.4d](#F4){ref-type="fig"}, open arrowheads), coincident with Pax6 expression in the closing neural tube at the same axial level. At more rostral levels, the cells in the mesodermal compartment with an intensity of Sox2 expression comparable to that in the neural tube formed Pax6-positive miniature neural tubes ([Fig.4e](#F4){ref-type="fig"}, white arrowheads). This result demonstrates that Sox2 expression is sufficient for the initiation of neural tube development from the primitive paraxial mesoderm, even in wild type embryos.

Finally, we asked whether the suppression of *Sox2* enhancer N1 activation by Tbx6 involves direct interaction of the Tbx6 protein with the enhancer N1 DNA sequence. Various overlapping fragments of the N1 sequence were tested for Tbx6 binding using electrophoretic mobility shift assays (EMSA). None of the N1 subfragments exhibited T-box factor binding capacity, under the condition where all known T-box-binding sequences strongly bound Tbx6 ([Supplementary Fig 6](#SD3){ref-type="supplementary-material"}), indicating that the suppression of the enhancer N1 activity by Tbx6 is probably not a direct regulation.

As enhancer N1 is activated by synergistic action of Wnt and Fgf signals[@R4] ([Fig.1](#F1){ref-type="fig"}), we investigated the expression patterns of the genes encoding these protein ligands in the CLE and paraxial mesoderm[@R19]-[@R22]. A remarkable change was observed in the expression pattern of *Wnt3a* ([Fig.2k,l](#F2){ref-type="fig"}). In normal embryos, *Wnt3a* expression is strongly expressed in the primitive streak, CLE and caudal neural plate, while its level is very low in the paraxial mesoderm ([Fig.2k](#F2){ref-type="fig"}). In *Tbx6* mutant embryos, however, the strong *Wnt3a* expression extends to the paraxial mesoderm compartment ([Fig.2l](#F2){ref-type="fig"}). On the other hand, the expression patterns of *Wnt8a* (absent in the mesoderm), *Fgf8* and *Fgf4* in the CLE and paraxial mesoderm compartment were not significantly altered in the *Tbx6* mutant embryos ([Supplementary Fig.7](#SD3){ref-type="supplementary-material"}). We hypothesize that Wnt3a expression, normally repressed in the paraxial mesoderm is de-repressed in the *Tbx6* mutant embryos, and the strong Wnt3a expression in the paraxial mesoderm is causative of the ectopic activation of enhancer N1, as schematized in [Fig.4f](#F4){ref-type="fig"}. The strong spatial correlation between *Wnt3a* expression and enhancer N1 activity observed at various axial levels in both wild type and *Tbx6* mutant embryos lends support for this model ([Fig.2i-l](#F2){ref-type="fig"}).

As discussed above, a significant fraction of the cells in the CLE domain have been shown to serve as the common precursors for the neural plate and paraxial mesoderm[@R8]. The present study clarifies the core regulatory circuit underlying the neural versus mesodermal dichotomous fate choice in the axial precursors, where *Sox2* expression is regulated by Tbx6 activity. As schematized in [Fig.4f](#F4){ref-type="fig"}, the mechanism to activate *Sox2* transcription operates first in CLE, namely enhancer N1 activation, and while this mechanism is still idle under the BMP-dependent *Sox2* repression, a fraction of the cells migrate into the mesodermal compartment, where the activity of enhancer N1 is lost, likely due to the very low Wnt activity. *Tbx6*-dependent mesodermal development is then promoted. Tbx6 appears to have two major functions, inhibition of *Sox2* activation via enhancer N1, and activation of the mesoderm specification program. The former function is important for the latter, as Sox2 misexpression in wild type embryos transforms paraxial mesoderm into neural tissue ([Fig.4c-e](#F4){ref-type="fig"}). In the *Tbx6* mutant embryos, persistent enhancer N1 activity owing to a high Wnt3a level in the mesodermal compartment causes ectopic *Sox2* expression, which is followed by expression of other neural specification genes, indicating that the *Sox2* expression provides the ground state for further neural development.

The long-held view that segregation of three germ layers determines cell lineages is challenged by cell lineage analyses[@R1],[@R2],[@R7],[@R8] and this study, which indicate that a pool of bipotential precursor cells in the CLE serves as axial stem cells that concordantly produce neural tube and paraxial mesoderm. This characteristic of CLE is continuous with the chordo-neural hinge at later stages[@R8],[@R10]. Thus, the three germ layers describe spatial organization of tissues, but do not indicate the process of tissue derivation. Our evidence reinforces the axial stem cell model by providing the mechanistic basis for the fate choice, namely that Tbx6-dependent regulation of *Sox2* determines the neural versus mesodermal fates in the axial stem cells derived from the CLE.

Methods summary {#S1}
===============

In situ hybridization and immunostaining were performed to analyze expression of relevant gene transcripts and protein products, respectively. Targeted knockout mice were used to analyze the consequence of loss in embryo of *Tbx6* and/or *Sox2* enhancer N1, and transgenic mice to monitor enhancer N1 activity or to ectopically express Sox2. EMSA analysis was to examine possible interaction of Tbx6 with enhancer N1 sequence.

Supplementary Material {#SM}
======================
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In situ hybridization {#S4}
=====================

Whole mount in situ hybridization was done as previously described by Wilkinson[@R26] with the following modifications: Proteinase K treatment was done at 5 μg/ml (E8 embryos) or 10 μg/ml (E9 embryos) for 5min; incubation with glycine after Proteinase K treatment was omitted; digoxigenin-labeled probes were used at 0.5 μg/ml; and anti-digoxigenin antibody was reacted in 1.5% Blocking Reagent (Roche). The stained embryos were photographed in 80% Glycerol/PBT, then embedded in paraffin and sectioned. The probes used: *Tbx6*[@R13], *Pax6*[@R27], *Uncx4.1*[@R28], *Foxf1*[@R29], *Pax2*[@R30], *Foxa1*[@R31], *Wnt8a*[@R32], *Fgf8*[@R33], *Fgf4*[@R34], *Sox1* 3′ UTR (*Stu*I-*Xho*I fragment), *Sox2* (*Sac*II-*Acc*I coding sequence fragment), *Sox3* (627-1128 bp, Genbank NM_009237), *Pax3* (*Hin*dIII-*Pst*I coding sequence fragment), *Mox1* (1688-2235 bp, Genbank NM_010791), *Egfp* (full coding sequence), and *Wnt3a* (a combination of probes for *Wnt3a* 3′UTR[@R35] and the *Wnt3a* coding sequence).

Immunostaining {#S5}
==============

Embryos were fixed overnight with 4% PFA in PBS, immersed in 15% and 25% sucrose in PBS in sequence for 2-3 hr each step, and embedded in OCT compound. Cryosections with thickness of 10 μm were prepared, and treated at 105° C for 15 min in antigen unmasking solution (Vector Laboratories) using an autoclave, which also quenched Venus fluorescence. The sections were reacted with 10% normal donkey serum for 30 min, then with the primary antibodies overnight at 4 °C. The primary antibodies, used at 1:200 dilutions, were: rabbit anti-Laminin (L9393 Sigma), goat anti-Sox2 (AF2018 R&D Systems), rabbit anti-Pax6 (PRB-278 Covance), and rat anti-HA (1867423 Roche). After several washes, the samples were incubated with fluorescent dye-coupled secondary antibodies for 1 hr at ambient temperature. The following donkey antibodies were used at 1:200 dilutions: Alexa Fluor 488-labeled anti-goat IgG (A-11055 Molecular Probes), Alexa Fluor 555-labeled anti-rabbit IgG (A-31572 Molecular Probes), and CF 633-labeled anti-rat IgG (20137 Biotium). After several washes the samples were stained with 0.5 μg/ml Hoechst33342, and mounted in Permafluor (Thermo Scientific).

Transgenic mouse production, LacZ staining and embryo transfection {#S6}
==================================================================

Transgene DNA constructs were linearized by digestion with restriction enzyme, freed from vector sequences. Injection of DNA (4 ng/μl) into the male pronucleus of fertilized eggs and LacZ enzyme staining were done using the standard procedures[@R36]. Mice had genetic backgrounds derived from \[C57BL/6 x DBA\] crosses. N1-tk*LacZ*[@R6] and N1-tk*Egfp* were used to establish transgenic lines, while other transgenes were used in primary transgenic embryos. The integration of transgenes into embryo genomes was determined by PCR amplification of the *LacZ* or *Egfp*/*Venus* sequences from yolk sac DNA. Embryo culture and mesodermal transfection with pCAGGS-cNoggin[@R4] were done as described previously[@R37].

Production of enhancer N1 mutant mice {#S7}
=====================================

The targeting vector used to create the enhancer N1 mutation was constructed by using a 15 kb mouse DNA fragment, which including enhancer N1, derived from the BAC clone RP23-274P9 (BACPAC Resource Center, Children's Hospital Oakland Research Institute, CA, USA). The STneoB cassette[@R38] was inserted 3′ of enhancer N1, loxP sequences were inserted to flank these sequences, and a DT-A cassette[@R39] was inserted at the 3′ terminus of the vector. The linearized vector was electroporated into R1 ES cells, which had been engineered to have IRES-EGFP immediately downstream of the *Sox2* ORF. Recombinants were characterized by Southern hybridization. After germ-line transmission from chimeras, heterozygous mice were crossed with CAGGS-Cre mice[@R40] to obtain the N1-deleted allele of *Sox2*. A schematic of the procedure is shown in [Supplementary Figure 4](#SD3){ref-type="supplementary-material"}.

Electrophoretic mobility shift assay (EMSA) {#S8}
===========================================

Full length Tbx6 (436 a.a.) was synthesized using a TNT system (Promega), and EMSA analysis was performed as described previously[@R41] using 0.1 μg/μl poly\[dI-dC\] as a non-specific competitor. The probe sequences used[@R15],[@R42],[@R43] are indicated in [Supplementary Figure 6](#SD3){ref-type="supplementary-material"}.

![Enhancer N1 of the mouse *Sox2* gene and its activity in comparison with *Sox2* and *Tbx6* expression\
**a.** The position of enhancer N1 relative to the *Sox2* ORF and the N1 core sequence bearing the conserved Lef1-binding elements and Fgf-responsive element (FgfRE). **b.** Expression of *Sox2* in E8.5 normal embryo in dorsal view. **c.** Enhancer N1 activity at the same stage, indicated by the expression of enhancer N1-LacZ transgene in primary transgenic embryos. ZCNP, zone at the caudal end of neural plate. **d,e.** The loss of enhancer activity by the mutations in both Lef1 elements (**d**, mutWnt) or in FgfRE (**e**, mutFgf)[@R4] in the transgenic embryos. **f.** *Tbx6* expression in E8.5 mouse embryo detected by in situ hybridization. **f',f".** The cross sections at the node (n)(**f'**) and primitive streak (ps)(**f")** levels. NP, neural plate; CLE, caudal lateral epiblast; PAM, paraxial mesoderm. Scale bars, 200 μm (**b**-**e**); 50 μm (**f'**,**f"**).](ukmss-33673-f0001){#F1}

![Ectopic activation of enhancer N1, *Sox2* expression and neural development in the paraxial mesoderm compartment of *Tbx6*−/− embryos\
**a,b.** *Sox2* expression in wild type and *Tbx6*−/− embryos at E8.5, shown by whole mount in situ hybridization. **a',a",b',b".** Transverse sections at the axial levels anterior to and through the node (n). NP, neural plate. Arrowheads, *Sox2* expression in the paraxial mesodermal compartment in *Tbx6*−/− embryo. **c,d.** *Sox2* expression in wild type and *Tbx6*−/− embryos at E9.5. NT, neural tube. Arrowheads, development of *Sox2*-positive ectopic neural tubes. **e,f.** and **g,h.** *Sox1* and *Sox3* expression, respectively, in wild type and *Tbx6*−/− embryos at E8.5. **i**,**j.** Activity of enhancer N1 at E8.5 in wild type embryos (**i**) or in *Tbx6*−/− embryos (**j**) detected by in situ hybridization of *Egfp* transcripts. **i'**,**i"**,**j'**,**j".** Their transverse sections at the node (n) and primitive streak (ps) levels. In wild type embryos, enhancer N1 activity was absent in the paraxial mesoderm compartments (PAM) (**i',i"**), whereas a strong N1 activity was demonstrated in the PAM in *Tbx6*−/− embryos (**j',j"**). Enhancer activity was detected in the node and endoderm (e) in either genotype. **k,l.** Expression of *Wnt3a* at E8.5 in wild-type embryos (**k**) or *Tbx6*−/− embryos (**l**) detected by in situ hybridization, in transverse sections at a primitive streak level. Scale bars, 50 μm.](ukmss-33673-f0002){#F2}

![Enhancer N1-dependent paraxial *Sox2* expression and ectopic neural tube development in *Tbx6*−/− embryos, and their suppression in *Tbx6*−/−;ΔN1/Δ N1 double mutants\
**a-d.** Effects of the enhancer N1 mutation (ΔN1/ΔN1) on *Sox2* expression in the neural plate and paraxial tissues in wild type and *Tbx6*−/− embryos at E8.5. Arrows: the position of node. The CLE, encircled by a broken line, and ZCNP (zone at the caudal end of neural plate) are indicated. *Sox2* expression in the ZCNP is lost in the enhancer N1 mutant embryos. **c,c',d,d'.** The loss of *Sox2* expression in the paraxial mesoderm compartment in *Tbx6*−/− embryos (**c'**) by the enhancer N1 mutation (**d'**), demonstrated by sections of embryos of relevant genotypes (**c**,**d**) at the axial levels indicated. Embryo specimens in **c** and **d** are overstained to confirm the absence of *Sox2* in the paraxial mesoderm compartment. **e-g.** Expression of *Sox2* (**e**, neural), *Pax6* (**f**, neural), *Pax3* (**g**, both neural and mesodermal) was examined in embryos of respective genotypes at E9.5. Scale bar, 50 μm.](ukmss-33673-f0003){#F3}

![Development of ectopic neural tubes from the wild type paraxial mesoderm by misexpression of exogenous Sox2\
**a.** Structure of the transgene. Msd enhancer of *Dll1* gene[@R18] in a dimeric form was used for paraxial mesoderm-specific activation of the transgene coding for Venus and HA~3~-tagged Sox2 joined with a 2A peptide sequence[@R23]. **b.** Mesodermal precursor-specific activation of Venus in transgenic embryos at E8.5. **c-e.** Cross sections at axial levels shown in (**b**). Immunofluorescence for Sox2, Pax6, and HA-tag, and Hoechst33342 staining, and a comparison with Sox2 immunofluorescence of normal embryos. Scale bar, 50 μm. **f.** Model of enhancer N1 regulation and enhancer N1-dependent *Sox2* activation in normal and *Tbx6*−/− embryos. In the CLE (left), where Wnt signal is above threshold, enhancer N1 is activated, however despite this *Sox2* expression itself is repressed by the inhibitory effect of BMP signals. In the ZCNP (right, top), where the Wnt signal stays ON, the relief from the BMP-mediated inhibition effectuates enhancer N1-dependent activation of *Sox2* expression in the caudal neural plate. In the paraxial mesoderm (right, bottom), although the BMP signal is downregulated[@R24],[@R25], Wnt signal drops below the threshold required for the activation of enhancer N1 when Tbx6 activity is present, and *Sox2* expression is not activated.](ukmss-33673-f0004){#F4}

[^1]: **Author Contributions**: TT and HK conceived the project, TT carried out major experiments, TT and HK analyzed data, MU and MY aided production and analysis of enhancer N1 mutant mice, VEP provided Tbx6 mutant mice, DMB, RL-B and VEP first indicated *Sox2* disregulation in the *Tbx6* mutant mice, and TT and HK wrote the manuscript.

[^2]: **Author Information**: Reprints and permissions information is available at [www.nature.com/reprints](http://www.nature.com/reprints). The authors declare no competing financial interests. Readers are welcome to comment on the online version of this article at [www.nature.com/nature](http://www.nature.com/nature). Correspondence and requests for materials should be addressed to H.K. (<kondohh@fbs.osaka-u.ac.jp>).
